Patents by Inventor William Windsor

William Windsor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210024548
    Abstract: Provided herein are boron-containing compounds, pharmaceutical compositions comprising such compounds, and methods of using such compounds to treat diseases or disorders.
    Type: Application
    Filed: May 22, 2020
    Publication date: January 28, 2021
    Inventors: Ronald T. Raines, Ian William Windsor, Brian James Graham
  • Publication number: 20070043045
    Abstract: Inhibitors of cyclin dependent kinase 2, compositions including the inhibitors, and methods of using the inhibitors and inhibitor compositions are described. The inhibitors and compositions including them are useful for treating disease or disease symptoms. The invention also provides for methods of making CDK-2 inhibitor compounds, methods of inhibiting CDK-2, and methods for treating disease or disease symptoms.
    Type: Application
    Filed: August 16, 2006
    Publication date: February 22, 2007
    Inventors: Yongqi Deng, Lianyun Zhao, Gerald Shipps, Patrick Curran, M. Siddiqui, Rumin Zhang, Charles McNemar, Todd Mayhood, William Windsor, Emma Lees, David Parry
  • Publication number: 20060229249
    Abstract: The present invention discloses peptide substrates of a proteolytic ADAM33 polypeptide. The present invention also discloses methods of identifying additional substrates of a proteolytic ADAM33 polypeptide. Furthermore, the present invention discloses methods of identifying compounds that inhibit the proteolytic activity of a proteolytic ADAM33 polypeptide.
    Type: Application
    Filed: June 20, 2006
    Publication date: October 12, 2006
    Inventors: Rumin Zhang, Jun Zou, Feng Zhu, James Durkin, William Windsor, Shelby Umland
  • Publication number: 20050037383
    Abstract: The present invention discloses modified Hdm2 proteins that are soluble. In addition, the present invention discloses nucleic acids that encode the modified Hdm2 proteins of the present invention. The invention also provides crystals of modified Hdm2 proteins that are suitable for X-ray crystallization analysis. The present invention also discloses methods of using the modified Hdm2 proteins and crystals thereof to identify, select and/or design compounds that may be used as anticancer agents. The present invention further discloses compounds that bind to modified Hdm2 proteins in protein-ligand complexes.
    Type: Application
    Filed: April 9, 2004
    Publication date: February 17, 2005
    Inventors: Shahriar Taremi, Gaolian Xie, Thomas Hesson, Jose Duca, Corey Strickland, William Windsor, Vincent Madison, Rumin Zhang, Paul Reichert